These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 11076004)

  • 61. [Sneddon's syndrome and systemic lupus erythematosus with cerebrovascular disturbances and widespread livedo].
    Kalashnikova LA; Dobrynina LA; Reshetniak TM; Aleksandrova EA; Lozhnikova SM; Gulevskaia TS; Nasonov EL
    Zh Nevrol Psikhiatr Im S S Korsakova; 2005; 105(7):21-5. PubMed ID: 16117142
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Neurological picture. Familial Sneddon's syndrome with microbleeds in MRI.
    Llufriu S; Cervera A; Capurro S; Chamorro A
    J Neurol Neurosurg Psychiatry; 2008 Aug; 79(8):962. PubMed ID: 18645217
    [No Abstract]   [Full Text] [Related]  

  • 63. Neuropsychological deficits in patients with Sneddon's syndrome.
    Weissenborn K; Rückert N; Ehrenheim C; Schellong S; Goetz C; Lubach D
    J Neurol; 1996 Apr; 243(4):357-63. PubMed ID: 8965111
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Sneddon's syndrome: a vascular systemic disease with kidney involvement?
    Macário F; Macário MC; Ferro A; Gonçalves F; Campos M; Marques A
    Nephron; 1997; 75(1):94-7. PubMed ID: 9031277
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cerebral microembolism in patients with Sneddon's syndrome.
    Sitzer M; Söhngen D; Siebler M; Specker C; Rademacher J; Janda I; Aulich A; Steinmetz H
    Arch Neurol; 1995 Mar; 52(3):271-5. PubMed ID: 7872880
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Moyamoya syndrome associated with Sneddon's syndrome and antiphospholipid-protein antibodies.
    Carhuapoma JR; D'Olhaberriague L; Levine SR
    J Stroke Cerebrovasc Dis; 1999; 8(2):51-6. PubMed ID: 17895140
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Moyamoya in a patient with Sneddon's syndrome.
    Fierini F; Barilaro A; Giambene B; Carlucci G; Grandi V; Maio V; Pantoni L
    Clin Neurol Neurosurg; 2015 Feb; 129():34-6. PubMed ID: 25528372
    [No Abstract]   [Full Text] [Related]  

  • 68. [Livedo reticularis, cerebrovascular disorders and mitral disease: a new cause of Sneddon's syndrome?].
    Vaillant L; Larmande P; Arbeille B; Desveaux B; Gruel Y; Lorette G
    Ann Dermatol Venereol; 1990; 117(12):925-30. PubMed ID: 2082786
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Recurrent stroke, acrocyanosis and livedo racemosa: is it always Sneddon's syndrome?].
    Martínez-Martín A; Hernández-Fernández F; Molina-Nuevo JD; López-Martínez A; Segura T
    Rev Neurol; 2020 Mar; 70(6):231-232. PubMed ID: 32149383
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sneddon's syndrome and antiphospholipid antibodies.
    Aznar J; Villa P; Yayá R; Ferrando F; Estellés A; Vallés J; Santos MT
    Thromb Res; 1993 Mar; 69(6):555-60. PubMed ID: 8503124
    [No Abstract]   [Full Text] [Related]  

  • 71. Cerebral glucose metabolism in Sneddon's syndrome associated with antiphospholipid antibodies.
    Juengling FD; Kassubek J; Weiner SM
    Lupus; 2001; 10(4):309-10. PubMed ID: 11341110
    [No Abstract]   [Full Text] [Related]  

  • 72. Tremor as the first neurological manifestation of Sneddon's syndrome.
    Da Silva AM; Rocha N; Pinto M; Alves V; Farinha F; Correia AP; Coelho T; Magalhães M
    Mov Disord; 2005 Feb; 20(2):248-51. PubMed ID: 15382213
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Cerebrovascular disorders associated with livedo (Sneddon's syndrome): its relation to lupus anticoagulant].
    Kalashnikova LA; Prudnikova LZ; Nasonov EP
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1990; 90(7):104-7. PubMed ID: 2175072
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Echocardiographic features in antiphospholipid-negative Sneddon's syndrome and potential association with severity of neurological symptoms or recurrence of strokes: a longitudinal cohort study.
    Assan F; de Zuttere D; Bottin L; Tavolaro S; Courvoisier DS; Barbaud A; Alamowitch S; Francès C; Chasset F
    Eur Heart J Cardiovasc Imaging; 2021 Jan; 22(1):119-128. PubMed ID: 31898726
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Antibodies to glutamate receptor subtype 3 (GluR3) are found in some patients suffering from epilepsy as the main disease, but not in patients whose epilepsy accompanies antiphospholipid syndrome or Sneddon's syndrome.
    Ganor Y; Goldberg-Stern H; Blank M; Shoenfeld Y; Dobrynina LA; Kalashnikova L; Levite M
    Autoimmunity; 2005 Sep; 38(6):417-24. PubMed ID: 16278146
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [Sneddon's syndrome: 4 cases and a review of the literature].
    Abouzahir A; Bourazza A; Rafik R; Karouach K; Boutaleb N; Ouhabi H; Mosseddaq R; Ohayon V; Archane MI
    Rev Neurol (Paris); 2003 Dec; 159(12):1156-62. PubMed ID: 14978416
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Sneddon's syndrome associated with anticardiolipin antibody: a case report.
    Mutluer N; Yiğit A; Aydin N
    Acta Neurol Belg; 1992; 92(4):234-8. PubMed ID: 1441902
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Primary antiphospholipid syndrome with and without Sneddon's syndrome.
    Caldas CA; de Carvalho JF
    Rheumatol Int; 2011 Feb; 31(2):197-200. PubMed ID: 20012621
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Sneddon's syndrome].
    Kanda T
    Ryoikibetsu Shokogun Shirizu; 2000; (30 Pt 5):377-9. PubMed ID: 11057265
    [No Abstract]   [Full Text] [Related]  

  • 80. Histocompatibility class I and II antigens in extensive kindred with Sneddon's syndrome and related hypercoagulation disorders.
    Lousa M; Pardo A; Arnaiz-Villena A; Jimenez-Escrig A; Gobernado J
    Hum Immunol; 2007 Jan; 68(1):26-9. PubMed ID: 17207709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.